Esophageal Cancer Overview
UVA Cancer Center has a multidisciplinary team dedicated to caring for patients with esophageal disease, from benign esophageal conditions through the most advanced stages of esophageal cancer. Many of the patients that come through our doors are referred by outside physicians for a second opinion because of our extensive knowledge of these diseases, approaches to treatment, advanced surgical procedures and the latest in minimally-invasive and non-surgical therapies.
UVA Thoracic Surgeons - Top Tier in the Region
Collectively, our thoracic surgeons at the University of Virginia perform more than 150 major operations for diseases of the esophagus annually. The significant experience of our surgeons in managing esophageal cancer and benign esophageal conditions directly improves patient outcomes and is one of the primary reasons that we continue to treat more of these patients every year.
The key to successful management of esophageal cancer is a multidisciplinary approach to care. Evaluation of every case is performed in a group setting with experts in surgery, radiology, medical oncology, pathology, gastroenterology and more looking at each patient from all critical angles. By using this approach, we're positioned to deliver the most individualized treatment plans possible for our patients.
UVA Cancer Center was among the first to perform thoracoscopic surgery and uses the most minimally invasive surgical approach whenever possible. Through the extensive experience of our surgical team, we are well-suited to determine when a minimally-invasive surgical approach or video-assisted thoracic surgery (VATS) procedure is appropriate, and in cases where more invasive surgery is required, we are well-equipped to perform the necessary procedures.
Through the successful completion of well-conducted clinical trails, UVA Cancer Center has the latest in non-surgical treatment options available. Clinical trials in any phase can benefit patients who meet the criteria, which is not only an excellent consideration for those patients who qualify, but is critical in advancing the care for future patients as well. For some patients with esophageal cancer, clinical trials might be the best option and our physicians and researchers work together to find a trial that has the most potential for a positive outcome.